Related Experiment Video

Updated: Aug 19, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

[Identification of new substrates of cyclin-activated kinases in breast cancers]

R Lilischkis1, E Barczak, M Marwedel

  • 1Institute für Pathologie, Medizinische Hochschule Hannover.

Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|March 16, 2002
PubMed

Insights

Researchers identified new substrates for cyclin E/CDK2 complexes, crucial for cell cycle control in breast cancer. This discovery may lead to novel diagnostic and therapeutic targets for breast cancer patients.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Cell cycle progression is regulated by cyclin-dependent kinases (CDKs) and their cyclin partners.
  • Cyclin E/CDK2 complexes play a role in cell cycle control, and their overexpression is linked to poor prognosis in breast cancer.
  • The specific in vivo substrates of cyclin E/CDK2 remain largely undefined.

Purpose of the Study:

  • To identify novel in vivo substrates of the cyclin E/CDK2 complex.
  • To advance the understanding of cell cycle regulation mechanisms in breast cancer.
  • To explore potential new targets for breast cancer diagnosis and treatment.

Main Methods:

  • Screening of nuclear extracts from breast cancer cells.
  • Utilizing a spotted-array protein library with purified active cyclin E/CDK2 complexes.
  • Expression and purification of active cyclin E/CDK2 complexes from insect cells.

Main Results:

  • Several potential substrates for cyclin E/CDK2 were isolated using the described methods.
  • The identified proteins represent candidates for in vivo substrates of cyclin E/CDK2.
  • Further validation studies are ongoing to confirm substrate authenticity.

Conclusions:

  • The identification of novel cyclin E/CDK2 substrates is a significant step in understanding cell cycle dysregulation in breast cancer.
  • These findings may pave the way for developing new diagnostic markers or therapeutic strategies.
  • Continued research into these substrates could unravel complex cell cycle control mechanisms.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...